A detailed history of Farringdon Capital, Ltd. transactions in Smith & Nephew PLC stock. As of the latest transaction made, Farringdon Capital, Ltd. holds 39,764 shares of SNN stock, worth $1.3 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares
39,764
Previous 52,828 24.73%
Holding current value
$1.3 Million
Previous $1.62 Billion 10.82%
% of portfolio
0.37%
Previous 0.54%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$29.33 - $38.7 $383,167 - $505,576
-13,064 Reduced 24.73%
39,764 $1.44 Billion
Q2 2025

Aug 14, 2025

BUY
$24.97 - $30.63 $1.32 Million - $1.62 Million
52,828 New
52,828 $1.62 Billion

Others Institutions Holding SNN

About SMITH & NEPHEW PLC


  • Ticker SNN
  • Exchange OTC
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 435,348,000
  • Market Cap $14.2B
  • Description
  • Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabi...
More about SNN
Track This Portfolio

Track Farringdon Capital, Ltd. Portfolio

Follow Farringdon Capital, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farringdon Capital, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Farringdon Capital, Ltd. with notifications on news.